Zweig-DiMenna Associates’s Elevance Health ELV Stock Holding History

Zweig-DiMenna Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,800	Closed	-$432K	–	102
2019 Q3	$432K	Sell	1,800 -13,365	-88%	-$3.66M	0.04%	97
2019 Q2	$4.28M	Sell	15,165 -26,674	-64%	-$7.29M	0.41%	73
2019 Q1	$12M	Buy	+41,839	New	+$12.1M	1.34%	25
2018 Q4	–	Sell	-18,454	Closed	-$5.06M	–	139
2018 Q3	$5.06M	Buy	+18,454	New	+$4.79M	0.42%	79
2017 Q2	–	Sell	-2,600	Closed	-$430K	–	217
2017 Q1	$430K	Buy	+2,600	New	+$414K	0.04%	116
2015 Q4	–	Sell	-3,000	Closed	-$420K	–	262
2015 Q3	$420K	Buy	3,000 +1,300	+76%	+$195K	0.02%	159
2015 Q2	$279K	Sell	1,700 -3,070	-64%	-$491K	0.02%	159
2015 Q1	$737K	Sell	4,770 -27,010	-85%	-$3.85M	0.03%	149
2014 Q4	$3.99M	Sell	31,780 -196,169	-86%	-$24.2M	0.17%	122
2014 Q3	$27.3M	Sell	227,949 -91,705	-29%	-$10.5M	1.19%	25
2014 Q2	$34.4M	Buy	+319,654	New	+$32.9M	1.57%	13
2014 Q1	–	Sell	-2,700	Closed	-$249K	–	250
2013 Q4	$249K	Sell	2,700 -400	-13%	-$35.5K	0.01%	206
2013 Q3	$259K	Buy	+3,100	New	+$266K	0.01%	173

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

Zweig-DiMenna Associates's ELV Position: Q4 2019 in Review

Zweig-DiMenna Associates sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 1,800 shares — an estimated $432K sold.

Zweig-DiMenna Associates first reported a position in ELV in Q3 2013 and held it in 13 quarters. The position peaked at $34.4M in Q2 2014. 1,112 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

Zweig-DiMenna Associates reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
Zweig-DiMenna Associates sold 1,800 Elevance Health shares in Q4 2019, an estimated $432K.
Zweig-DiMenna Associates first reported a position in Elevance Health in Q3 2013 and held it in 13 quarters.
Zweig-DiMenna Associates's Elevance Health position peaked at $34.4M in Q2 2014.
1,112 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2019, filed 30 Jan 2020.